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OBJECTIVEdTo determine whether improvements in glycemic control and diabetes-speciﬁc
quality of life (QoL) scores reported in research studies for the type 1 diabetes structured edu-
cation program Dose Adjustment For Normal Eating (DAFNE) are also found when the inter-
vention is delivered within routine U.K. health care.
RESEARCHDESIGNANDMETHODSdBefore and after evaluation of DAFNE to assess
impact on glycemic control and QoL among 262 adults with type 1 diabetes.
RESULTSdThere were signiﬁcant improvements in HbA1c from baseline to 6 and 12 months
(from 9.1 to 8.6 and 8.8%, respectively) in a subgroup with suboptimal control. QoL was
signiﬁcantly improved by 3 months and maintained at both follow-up points.
CONCLUSIONSdLonger-term improved glycemic control and QoL is achievable among
adults with type 1 diabetes through delivery of structured education in routine care, albeit with
smaller effect sizes than reported in trials.
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Self-management training for type1 diabetes on the model of theD€usseldorf structured teaching and
treatment program (STTP) (1) has dem-
onstrated a wide range of positive health
and psychological outcomes within ran-
domized controlled trials (RCTs) (1–3),
and these effects are maintained wholly
or in part in the longer term (4). These
programs evolved in response to studies
demonstrating beneﬁts of intensiﬁed in-
sulin therapy (5,6).
Eligibility criteria used within RCT
mean trial populationsmay be unrepresen-
tative (7). We aimed to determine whether
improvements in glycemic control and
quality of life (QoL) reported in RCTs of
self-management training are found when
the program is delivered in routine U.K.
health care.
RESEARCH DESIGN AND
METHODSdAdults with type 1 diabe-
tes were recruited, consecutively, from 73
courses at 12 U.K. hospitals, representing
well-established (n = 8) and new centers
(n = 4). The Dose Adjustment For Normal
Eating (DAFNE) was selected as an exem-
plar of an STTP that has achieved wide-
spread adoption by service providers.
Efﬁcacy has been demonstrated, obviating
the need for a control group (2).
DAFNE comprises a 5-day course
with booster session 6 weeks later, de-
livered to groups of up to eight by two
trained diabetes educators. It promotes
ﬂexible, intensive, insulin therapy, sepa-
rating basal from prandial rapid-acting
insulin, and a ﬂexible, varied diet with no
forbidden foods. Dose adjustment de-
pends on preprandial and bedtime blood
glucose values. DAFNE is based on social
learning theory (8). The main topics are
carbohydrate counting and dose adjust-
ment, along with managing hypoglyce-
mia and illness. Eligibility criteria for
course enrolment were applied as follows:
1) type 1 diabetes for at least 6 months, 2)
.17 years of age, 3) absence of end-stage
complications (e.g., renal failure), and 4)
multiple daily injections
HbA1c data were collected from rou-
tine records up to 8 weeks before and 6
and 12 months after the course. Partici-
pants completed the Diabetes-Speciﬁc
Quality of Life Scale (DSQOLS) (9), be-
fore course enrollment and 3, 6, and 12
months after completion. Follow-up co-
incided with points at which HbA1c was
routinely determined in outpatients. The
3-month follow-up was included to allow
sufﬁcient time to observe short-term
changes in QoL. The DSQOLS was de-
signed to evaluate the D€usseldorf STTP,
on which DAFNE is based. Psychometric
validation of the scale in English used data
from this study and two others (10,11)
and will be reported elsewhere. The
DSQOLS includes 57 items that form six
subscales summed to gain a total score.
Higher scores indicate better QoL.
RESULTSdOf 474 patients ap-
proached, 262 (55%) participated. Basic
data, maintaining anonymity, permitted a
comparison between participants (n =
262) and those who declined or were
could not be contacted (n = 254). Non-
participants had slightly higher baseline
HbA1c (8.8 6 1.6% vs. 8.5 6 1.5% or
73 6 18 mmol/mol vs. 69 6 16 mmol/
mol; P = 0.02).
DSQOLS response rate was 74% at
each time point. HbA1c data were avail-
able for 78% of participants at 6 months
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and 93% at 12 months. There was no sex
imbalance. Average age was 406 14 years
(range, 17–73 years); mean duration of
diabetes was 18 6 13 years (range, 6
months–55 years); 89% were white Brit-
ish; 44% had a degree; 49% were in pro-
fessional or managerial occupations; 61%
were in full-time employment; and 68%
were in a signiﬁcant relationship. Mean
baseline HbA1c was 8.5 6 1.5% (70 6
16 mmol/mol), ranging from 5.4–14.2%
(36–132 mmol/mol). A quarter (n = 65)
had an HbA1c level ,7.5% (,58 mmol/
mol), which was regarded as acceptable
because further improvement would in-
crease the risk of severe hypoglycemia.
This subgroup was excluded from an
analysis of people with suboptimal
HbA1c.
Linear mixed models were run with
direct maximum likelihood to account
for missing data. For HbA1c in the total
group, there was signiﬁcant improve-
ment from baseline to 6 months (P ,
0.001) (Table 1), which was maintained
at 12 months (P, 0.001), although there
was a slight deterioration from 6 to 12
months (P , 0.05). In the subgroup
with an HbA1c level $7.5%, there was
a clinically and statistically signiﬁcant
improvement in HbA1c from baseline to
both follow-up points (6 months, P ,
0.0001; 12 months, P , 0.01), which
also showed a slight deterioration
from 6 to 12 months (P , 0.001).
Each DSQOLS subscale and total score
showed signiﬁcant improvements by
3 months, all of which were maintained
at 6 and 12 months in the total sample
(Table 1).
CONCLUSIONSdAmong adults
with type 1 diabetes undergoing skills-
based training in routine U.K. health care,
there was a clinically relevant improve-
ment in HbA1c in the total sample, which
was, unsurprisingly, larger in those with
suboptimal control (HbA1c $ 7.5%) be-
fore the course. This was accompanied by
signiﬁcant improvement in QoL, fully
maintained at 1-year follow-up, as demon-
strated in previous RCTs (4) and reported
from audit data (12,13). Statistically, the
improvement in glycemic control was
only slightly reduced by 12 months,
mirroring the DAFNE RCT, the Epidemi-
ology of Diabetes Interventions and Com-
plications (EDIC) study, the EURODIAB
cohort, and the DAFNE Database Study
(2,5,6,14).
Study strengths include the observa-
tional design and relatively large numbers.
Limitations include the high proportion of
well-educated subjects and the lack of a
control group, although the current ﬁnd-
ings reﬂect similar results to the DAFNE
and STTP RCTs. Limited data were avail-
able for nonrespondents who had a higher
baseline HbA1c.
The 0.5% reduction in HbA1c by 6
months in the group with suboptimal
baseline HbA1c is clinically signiﬁcant,
reﬂecting a small effect size (15). The ini-
tial improvement in QoL at 3 months was
equivalent to just under a medium effect
size (15). The maintenance of effects from
baseline to 12 months suggests that im-
provements in HbA1c and QoL were at-
tributable to the DAFNE intervention.
The reduction in themagnitude of change
relative to the original DAFNE RCT (2)
may reﬂect the higher proportion of par-
ticipants with baseline HbA1c values
closer to target. DAFNE audit data dem-
onstrate signiﬁcant improvements in fre-
quency of severe hypoglycemia and
hypoglycemia awareness (14). These ben-
eﬁts are only seen by not restricting
DAFNE to people with suboptimal
HbA1c.
Although it seems that the effects on
glycemic control attenuate somewhat
with time, it is possible to achieve sustain-
able improvements in HbA1c and QoL
among adults with type 1 diabetes dur-
ing routine delivery of structured educa-
tion, This is encouraging given the rollout
of DAFNE both nationally and interna-
tionally.
Table 1dHbA1c results and DSQOLS scores across four time points
Baseline 3 months 6 months 12 months
x2 test for differences between means
Baseline vs. ﬁrst
follow-up*
Baseline vs.
12 months
Follow-up
comparison†
HbA1c total sample
HbA1c 8.5 (1.5) d 8.2 (1.5) 8.3 (1.6) 22.0, df = 1, P , 0.001 6.0, df = 1, P , 0.05
10.1, df = 1,
P , 0.001
IFCC 70 (16) d 66 (16) 68 (17)
HbA1c subgroup $7.5%
(58 mmol/mol)
HbA1c 9.1 (1.6) d 8.6 (2.0) 8.8 (2.5) 36.8, df = 1, P , 0.001 14.8, df = 1, P , 0.001
8.5, df = 1,
P , 0.01
IFCC 76 (14) d 70 (16) 72 (17)
DSQOLS
Social aspects 76.8 (18.5) 81.7 (17.4) 81.6 (16.7) 80.9 (17.3) 31.6, df = 1, P , 0.001 18.5, df = 1, P , 0.001 1.2, df = 2, NS
Fear of hypoglycemia 69.5 (22.2) 75.0 (21.6) 75.0 (21.9) 74.4 (22.3) 23.0, df = 1, P , 0.001 14.5, df = 1, P , 0.001 0.4, df = 2, NS
Dietary restrictions 65.3 (23.5) 80.2 (21.9) 78.5 (21.4) 78.7 (21.1) 89.5, df = 1, P , 0.001 76.3, df = 1, P , 0.001 2.9, df = 2, NS
Physical complaints 72.5 (19.9) 78.1 (19.3) 79.1 (17.5) 78.2 (19.5) 32.1, df = 1, P , 0.001 25.2, df = 1, P , 0.001 2.0, df = 2, NS
Anxiety about the
future 44.5 (27.4) 53.2 (27.2) 53.8 (26.8) 53.6 (28.2) 33.7, df = 1, P , 0.001 30.5, df = 1, P , 0.001 0.3, df = 2, NS
Daily hassles 56.1 (25.2) 63.1 (27.2) 64.4 (25.9) 63.9 (25.3) 21.0, df = 1, P , 0.001 27.6, df = 1, P , 0.001 1.3, df = 2, NS
Total score 68.3 (17.6) 75.4 (17.5) 75.5 (16.8) 75.0 (17.5) 60.6, df = 1, P , 0.001 49.3, df = 1, P , 0.001 0.7, df = 2, NS
Data are mean (SD). IFCC, International Federation of Clinical Chemistry and Laboratory Medicine. *Comparisons are baseline vs. 6 months for HbA1c and baseline
vs. 3 months for DSQOLS. †Comparison is 6 vs. 12 months for HbA1c, and comparison is among 3, 6, and 12 months for DSQOLS.
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